Anika Therapeutics (ANIK) Revenue Growth (5y) (2015 - 2026)
Anika Therapeutics (ANIK) Revenue Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.02 Bn | 32.28 Bn | 1.97 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.94 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.35 Bn | 18.54 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Anika Therapeutics | 203.64 Mn | 136.85 Mn | 19.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.89% |
| Dec 31, 2025 | -1.30% |
| Sep 30, 2025 | -2.58% |
| Jun 30, 2025 | -1.66% |
| Mar 31, 2025 | -5.86% |
| Dec 31, 2024 | 0.55% |
| Sep 30, 2024 | -0.09% |
| Jun 30, 2024 | 0.20% |
| Mar 31, 2024 | 3.26% |
| Dec 31, 2023 | -16.08% |
| Sep 30, 2023 | 9.13% |
| Jun 30, 2023 | 7.72% |
| Mar 31, 2023 | 12.27% |
| Dec 31, 2022 | -15.94% |
| Sep 30, 2022 | 8.17% |
| Jun 30, 2022 | 3.46% |
| Mar 31, 2022 | 9.43% |
| Dec 31, 2021 | 4.83% |
| Sep 30, 2021 | 8.92% |
| Jun 30, 2021 | 7.50% |